2024 Sec filing immatics

Sec filing immatics

Author: slbf

August undefined, 2024

WebSEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. WebUNITED STATES . SECURITIES AND EXCHANGE COMMISSION . Washington, D.C. 20549 . FORM 6-K. REPORT OF FOREIGN PRIVATE ISSUER . Pursuant to Rule 13a-16 or 15d-16. of the Securities Exc

SEC Filing Immatics N.V.

http://investors.immatics.com/node/7756/html Web23 Aug 2024 · The SEC requires all publicly traded companies, foreign and domestic, to disclose financial condition, operating results, management compensation, and other … employers overload eugene or

SEC Filing Immatics N.V.

Web11 May 2024 · Tuebingen, Germany and Houston, Texas, May 11, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the … WebGRAPHIC. g865842g98t61.jpg. GRAPHIC. 73618. Complete submission text file. 0001193125-20-108419.txt. 10648943. Mailing Address PAUL EHRLICH-STRASSE 15 TUBINGEN 2M 72076. Business Address TUBINGEN 2M 72076. Web25 Mar 2024 · Immatics (NASDAQ:IMTX – Get Rating) – Equities researchers at SVB Leerink issued their Q1 2024 EPS estimates for Immatics in a report issued on Tuesday, March 21st.SVB Leerink analyst J. Chang anticipates that the company will post earnings per share of ($0.42) for the quarter. The consensus estimate for Immatics’ current full-year earnings … employers pension obligations ireland

Advent Technologies Inc. - Financials - SEC Filings

Sec filing immatics

Web9 Jan 2024 · SEC Filing Immatics N.V. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER … Web14 Dec 2024 · In November 2024, Immatics filed a Clinical Trial Application with Paul-Ehrlich-Institute (PEI), the German federal regulatory authority, for the development of IMA401. The clinical trial, which is planned to commence in the first half of 2024, is expected to enroll patients across various solid tumor types.

Did you know?

Web4 Apr 2024 · SEC Filings. Date Filing Type Filing Description Download / View. 04/04/2024. SC 13G/A. Amended Statement of Ownership. 03/31/2024. 10-K. Annual Report. 03/31/2024. WebImmatics Biotechnologies GmbH is located at Paul-Ehrlich Str. 15 in 72076 Tübingen, Germany. Immatics Biotechnologies GmbH was founded in September 2000 as a German …

WebImmatics N.V. is a Dutch public limited liability company (naamloze vennootschap) incorporated on March 10, 2024 and the holding company of Immatics Biotechnologies … Web6 Jan 2024 · The Immatics Approach to Disrupt Current Tumor Treatment Paradigms Based on 5 Defined Principals True Cancer Targets & Matching Right TCRs Targeted Approach in …

Web15 Jul 2024 · Immatics’ Pipeline Addresses Significant Number of Cancer Patients Prevalence of MAGE4/8, MAGEA1 and PRAME in Major Solid Cancer Indications 9 Niche … WebImmatics N.V., a Dutch public limited liability company, was converted on July 1, 2024 from Immatics B.V., a Dutch company with limited liability. Immatics Biotechnologies GmbH …

WebSEC Filing Immatics N.V. As filed with the Securities and Exchange Commission on October 9, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE …

Web11 Oct 2024 · IMMATICS N.V. Paul-Ehrlich-Straße 15 . 72076 Tübingen, Federal Republic of Germany (Address of principal executive office) Indicate by check mark whether the … employers pension threshold 2022/23Web7 Jun 2024 · TUEBINGEN, Germany and HOUSTON and CAMBRIDGE, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Immatics N.V. (Nasdaq: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the... drawing for class 3Web14 Dec 2024 · In November 2024, Immatics filed a Clinical TrialApplication with Paul-Ehrlich-Institute (PEI), the German federal regulatory authority, for the development of … drawing for classWeb23 Mar 2024 · Immatics entered a global licensing agreement with Bristol Myers Squibb to collaborate on clinical development of TCR Bispecific (TCER ®) IMA401 targeting … drawing for class 8WebOn June 1, 2024, Immatics US, Inc. entered into a License, Development and Commercialization agreement (the “Allogeneic ACT agreement”) with Bristol-Myer … drawing for civil engineering textbookWeb21 Mar 2024 · Immatics N.V. (IMTX) SEC Filing 6-K Foreign Issuer Report for the period ending Wednesday, March 22, 2024. Home. SEC Filings. Immatics B.V. (IMTX) ... Immatics B.V. provided additional information to their SEC Filing as exhibits. Exhibit 99.1: Additional Exhibits. Exhibit 99.2: Additional Exhibits. Ticker: IMTX CIK: 1809196 employer sponsored 401 kWebImmatics Announces Third Quarter 2024 Financial Results and Business Update Immatics Announces $110 Million Underwritten Offering of Ordinary Shares Immatics Announces Full Year 2024 Financial Results and Corporate Update Our PIPELINE INVESTORS Our Mission drawing for class 2